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25 pL of the hybridoma supernatent into rows A1-Al2, and is serially
diluted 2-fold down the plate. The plate was allowed to incubate for 2
h at 37 "C, which was then followed by a deionized water wash/shaking
(10 times). All wells were next treated with 25 pL of a goat anti-mouse
glucose oxidase (Cappel) solution, which was diluted previously 1500 in
Blotto. The plate was allowed to incubate for 1 h at 37 "C. This was
followed by (lox) deionized water wash/shaking. The plate is finally
developed with 50 pL/well of a developing solution (25 mL, 0.2 M
sodium phosphate, pH 6.0, 3 mL, 2Wb glucosc/deionized water, 200 pL,
0.1% horseradish peroxidase/O.l M phosphate buffer, pH 6.0, 200 pL,
ABTS (BMB)) (45 mg/mL of deionized water). After 30 min the plate
(each well) absorbance was determined at 405 nm on a Molecular Devices (V-) kinetic plate reader.
A typical competition ELISA was performed in the following manner.
A 'limiting" antibody and antigen concentration as determined above is
used in the following manner. The BSA-hapten conjugate (concentration
determined above) in PBS is added at 25 pL/well to an ELISA plate.
Methanol fix was added at 50 pL/well for 5 min. The methanol is
removed, and the plate is air-dried for 10 min. The plate is blocked as
described above with Blotto (50 pL/well) at 37 "C for 30 min, and the
excess Blotto is removed. Next, the antigen (hapten) or substrate (diluted
1:20 in PBS-5% DMF) is serially diluted 2-fold (12 times). These
solutions (12.5 pL) (each dilution) are added to the ELISA plate in the
appropriate well, AI-Al2, followed by the antibody (concentration determined above) ( I 2.5 pL). This is allowed to incubate for 2 h at 37 "C.
The plates are washed with deionized water (lox), and goat anti-mouse
glucose oxidase is added (described above) followed by incubation for 1
h at 37 "C. The plate is again washed with deionized water (lox)
followed by the addition of developing solution (described above). Absorbances are read at 405 nm.
The data (absorbances) obtained were fitted to eq 2 where CP is the
absorbance determined and t is the antigen or substrate concentration.
P( I), P(2), P(3), and care adjustable parameters in the four-parameter
logistic fit.*'
CP =

p(l)

1 + P(2)tC

+ P(3)

Chemical Modification of Antibodies. (8) Pheayl@yox8l. A 50-pL
aliquot of a phenylglyoxal solution (6 mM, 125 mM NaHCO,. pH 7.5)
was added to buffer (195 pL; 125 mM, pH 7.5,NaHCO,) containing
antibody (20 pM). The mixture was vortexed and left to stand for 1 h
at room temperature. This was then transferred to a microdializer
(Pierce) and d i a l i d with 125 mM pH 7.5 NaHCO, with a flow-through
of approximately 150 mL/h for 2 h. This was then flushed with 4 X 60
mL portions of pH 8.4 50 mM CHES-100 mM NaCl and left to stand
in this buffer overnight. This was again flushed 3 X 50 mL portions of
pH 8.4 50 mM CHES-100 mM NaCl the next morning. Samples were
removed, protein concentrations recalculated (BCA), and assays run for
catalytic activity (HPLC) or binding (ELISA). A similar procedure was
used with hapten present (200 pM).
(b) Maleic Anhydride. A 5-pL aliquot of a maleic anhydride solution
(0.06 M, dioxane) was added to 229 pL of 20 mM pH 8.0 borate100
mM NaCl containing 20 pM of antibody. The solution was vortexed and
left to stand at room temperature for I h. This was then transferred to
a microdializer and dialyzed as described above with 50 mM phosphate,
pH 7-100 mM NaCl overnight, followed by 50 mM CHES, pH 8.4-100
mM NaCl for 2 h. Samples were removed, protein concentrations calculated (BCA), and assays run for catalytic activity or binding.
(c) Diethyl Pyrocarbonnte. A IO-pL aliquot of a 0.6 M diethyl pyrocarbonate solution in ethanol is diluted in 1 mL of NaOAc (150 mM,
pH 6-100 mM NaCI). Of this 5 pL is added to 229 pL of NaOAc (150
mM, pH 6.0-100 mM NaCI) containing 20 pM of antibody. The mixture is vortexed and left to stand at 4 "C overnight. This was then
transferred to a microdializer and dialyzed as described above with
CHES (50 m M CHES, pH 8.4-100 mM NaCI). Samples were removed, protei.. concentrations determined (BCA), and assays performed
for catalytic activity and binding.
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Abstract: A coupled kinetic analysis of esperamicin, calicheamicin, and DNase I cleavage of covalently closed circular PM2
DNA has been carried out. Analysis of the optical density data derived from agarose gel electrophoresis experiments shows
that esperamicin A,, like the hydrolytic enzyme DNase I, produces mainly single-strand breaks in DNA. These agents cause
covalently closed circular form I DNA to be initially converted to nicked circular form I1 DNA. However, the ratio of the
rate constant for this process (k,') to that associated with conversion of form I1 to linear form I11 DNA ( k i ) is not consistent
with completely random nicking, and some double-strand cleavage may occur. The values of k , ' / k i found for DNase I and
esperamicin A, were 5.4 nd 3.9, respectively. The behavior of these agents sharply contrasts with that of esperamicin C and
calicheamicin, for which double-strand cleavage of DNA is deduced from the analysis. Although the rate constant for introducing
the first break in DNA for calicheamicin is lower than the corresponding rate constant for esperamicin C, the second break
(in the opposing strand) is fast for calicheamicin, making it the better double-strand cleaving agent. These drugs are unique
among antitumor agents in that a single activation event on the warhead portion produces a double-strand break in DNA
without the need to posttreat the DNA with other agents in order to induce a cleavage. The cleavage kinetics are discussed
in terms of the structural differences in these unusual anticancer drugs.

The newly discovered anticancer drugs esperamicin1*2and
calicheamicin3*' (Figure 1) exhibit high potency against murine
tumor lines. These compounds possess sugar groups appended
to an unusual 1,5-diyn-3-ene core structure referred to as the
uwarheadn. In the presence of reducing agents and D N A the
*TOwhom correspondence should be a d d r d .

0002-7863/91/1513-5434$02.50/0

warhead undergoes a rearrangement to create a phenylene diradical that causw strand breaks by attacking the sugar groups
(1) Golik, J.; Clardy, J.; Dubay, G.; Groenewold, G.; Kawaguchi, H.;
Konishi, M.; Krishnan, B.;Ohkuma, H.; Saitoh, K.4.; Doyle, T. W.J. Am.
Chcm. Soc. 1987. 109. 3461-3462. Golik. J.: Dubav. G.: Groenwold. 0.:
Kawaguchi, H.;Konishi, M.;Krishnan. B.;Ohhma, H.i Saitoh, K.4.; Doyle;
T.W.Ibid. 1987, 109, 3461-3462.
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Figure 1. Structures of esperamicins A I and C and calicheamicin yt.

of DNA. An interesting feature of esperamicin and calicheamicin
as well as the chromophore of neocarzino~tatin~
is that a single
activation event produces 2 equiv of a species capable of reacting
with sites on DNA, Le., the phenylene diradical. This raises the
possibility that a single drug molecule, after activation, can react
with opposing strands to produce a double-strand break in DNA.
Since this type of lesion is more difficult to repair than a single-strand peak, it is possible that a high frequency of doublestrand breaks in DNA may be part of the basis for the extreme
cytotoxicity of this unusual class of antitumor agent.
The evidence that esperamicin and calicheamicin cleave DNA
via a double-strand process is primarily based on the drug-induced
cleavage pattern on opposite DNA strand^^.^ and in the case of
calicheamicin on labeling experiments showing that both radicals
of the phenylene diradical abstract hydrogen atoms from D N A 6
In the absence of additional information such as the absolute rate
processes for cleavage on both strands, it is not clear whether a
single activated "warhead" produces lesions on opposing strands,
Le., a double-strand peak, or whether the second peak is caused
by a second drug binding to the nicked site and subsequently
(2) Long, B. H.; Golik, J.; Forenza, S.; Ward, B.; Rehfuss, R.; Dabrowiak,
J. C.; Catino, J. J.; Musial, S. T.; Brookshire, K. W.; Doyle, T.W. Proc. Narl.
Acad. Sci. U.S.A. 1989,86,2-6.
(3) Lee, M. D.; Dunne, T. S.; Siegel, M. M.; Chang, C. C.; Morton, G.
0.;Borders, D. B. J. Am. Chem. Soc. 1987,109, 3464-3466. Lee, M. D.;
Dunne, T. S.; Chang, C.C.; Ellestad, G. A.; Siegel, M. M.; Morton, G. 0.;
McGahren, W. J.; Borders, D. B. Ibid. 1987, 109, 3466-3468.
(4) Zein, N.; Sinha, A. M.;McGahren. W. J.; Ellestad, G. A. Science
1988, 240, 1198-1201. Zein, N.; Poncin, M.; Nilakantan, R.; Ellestad, G.
A. Ibid. 1989. 244,697699.
( 5 ) Goldberg, I. H. Free Radical Biol. Med. 1987, 3. 41.
(6) Zein, N.; McGahren, W. J.; Morton, G. 0.;Ashcroft, J.; Ellestad, G.
A. J . Am. Chem. Soc. 1989, 111,6888-6890.

Figure 2. Photograph of agarose gel showing esperamicin C cleavage of
P V 2 DNA. The drug concentration in the various lanes, in order of
increasing drug concentration (left to right), can be found in the Experimental Section. Lane 1 is zero drug concentration. The various
forms of PM2 DNA, covalently closed circular (I), nicked circular (11),
and linear (111). are shown on the right of the figure.

causing a break in the opposite strand. In the case of neocarzinostatin, a "double-strand" break is the result of a break in
the sugar-phosphate backbone on one strand and the creation of
an apurinic/apyrimidic site two nucleotides away from the initial
break on the opposing DNA ~ t r a n d . ~Treatment of the modified
DNA with endonuclease IV or putrescine, agents that attack
apurinic/apyrimidic sites, is necessary in order to cause the second
break in DNA.
In this paper we examine the ability of esperamicins AI and
C and calicheamicin 7 ; to cleave closed circular PM2 DNA. The
cleavage data are quantitatively analyzed with use of coupled
kinetic models representing single- and double-strand cleavage
processes. For comparative purposes, we also analyze cleavage
of PM2 DNA by the hydrolytic enzyme DNase I under conditions
previously reported to yield single-strand breaks in DNA.'
PM2 DNA, a covalently closed circular DNA molecule that
is 9300 nucleotides long, is a convenient substrate for studying
the cleavage action of DNA-nicking drugs. An agent capable of
binding to DNA and yielding 1 equiv of a DNA-damaging group
from a single activation event would cause an initial break in the
PM2 genome, leading to the loss of supercoiling and the formation
of nicked circular form I 1 DNA. Subsequent binding and activation events would cause additional nicking of form I1 DNA.
If two breaks on opposing DNA strands were relatively close to
one another, the DNA segment between the breaks would "melt",
causing form I1 to be converted to the linear form, form 111 DNA.
Although DNA melting depends strongly on sequence as well as
other factor^,^ breaks on opposing strands up to 6-10 base pairs
apart would likely cause linearization of the DNA molecule under
the conditions used in this study.
Experimental Section
The esperamicins (esp) were obtained from J. Golik of Bristol-Myers
Squibb Co., Wallingford, CT, while the sample of calicheamicin yf was
obtained from G. Ellestad of Lederle Laboratories. Stock drug concentrations (-3 X IOa M) were made by dissolving weighed amounts of
the drugs, 1-3 mg, in ethanol. Dilutions necessary for the strand scission
work were done by adding a portion of the ethanol stock to a larger
volume of the aqueous buffer used in the study. The maximum concentration of ethanol introduced by this procedure in any of the cleavage
experiments was <I%. All DNA concentrations are stated in base pairs.
Cleavage of PM2 DNA. The cleavage of PM2 DNA by esperamicin
and calicheamicin was carried out in a total volume of 13 p L at 37 OC
for IO min in the buffer 6.2 mM Tris-HC1/0.6 mM EDTA, pH 7.5. To
2 p L of the solution containing DNA was added 8 p L of a solution
containing the drug, followed by 3 p L of the solution containing dithiothreitol (DTT). The final concentrations of PM2 DNA and DTT present
in the reaction medium were 9.4 X
M and 0.45 mM, respectively.
Concentrations of csp A,: 0.9.23 X
M; 1.38.4.62, 9.23 X 10-9 M;
(7) Povirk, L.;Houlgrove, C. W.; Hau, J.-H. J. Biol. Chem. 1988, 263,
19263- 19266.
(8) Campbell, V. W.; Jackson, D. A. J. Biol. Chem. 1980,255,3726-3735.
(9) Marky, L. A.; Breslauer, K. J. Proc. Natl. Acad. Sci. U S A . 1W.84,
4359-4363.
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4.62, 9.23 X IO4 M; 1.85, 4.62, 9.23 X
After a digest time of 10 min, the reaction was terminated by the addition
of 4 pL of a 3 X IO-' M sodium dodecyl sulfate %top" solution, and the
DNA was loaded onto a horizontal 0.8% agarose gel and electrophoresed.
After electrophoresis, the gel was soaked in a 0.5 pg/mL solution of
ethidium bromide for 1 h, placed on a UV transilluminator, and photographed with use of a Polaroid camera equipped with positive/negative
Type 55 film. The resulting negative was 'fixed" according to the
manufacturer's recommendation with aqueous 18% Na2S0,. A photograph of the stained gel for esp C is shown in Figure 2.
Cleavage of PM2 DNA was also carried out with use of DNase I in
a total volume of 7 p L of the buffer 14.3 mM Tris-HC1/9.1 mM
MgC12/2.3 mM CaCI2, pH 7.5. After proceeding for IO min, the reaction was terminated by addition of aqueous EDTA and the products were
loaded onto an agarose gel. Concentrations of DNase I (units/pL)
present in the various reactions: 1. I , 1.67, 2.22, 5.56 X lo4; 1.1, 1.67,
2.22, 5.56 X lW*; 1.1, 1.67, 2.22, 5.56 X IO-'; 1.1 X lod.
A Molecular Dynamics Model 300A microdensitometer capable of
whole-spot integration was used to scan the photographic negatives of the
agarose gel data. Control experiments (data not shown) showed that
measured densities on the negative were dependent on the placement of
the gel relative to the optical axis of the camera and to a certain extent
on the gel's location on the UV transilluminator. The intensity varied
smoothly from a maximum in the center of the negative to minima at
both edges. In order to correct for these experimental effects as well as
errors due to loading slightly different amounts of DNA into the wells
of the gel, the sum of the intensities of the three DNA forms for each

8

'

.-

_

0.001

-43'
-

r

- rnm.

.

b
.a
7

0.01

~

'

~

*

~

f

,

8

7 1

0.1

[Esperamicin], pM

1

Figure 3. Intensities for forms I, 11, and I11 DNA resulting from DNase
I cleavage of PM2 DNA as a function of DNase I concentration. Intensities calculated by the single-strand (A) and double-strand (B) models
described in the text are open symbols. Curves are fits to calculated
intensities.

1

Figure 4. Intensities for forms I, 11, and I11 DNA resulting from es-

peramicin AI cleavage of PM2 DNA as a function of concentration of
esperamicin AI. See caption to Figure 3 for further details.
lane was adjusted to a constant value. The maximum value of the correction factor was 1.9. Lanes for which this type of correction would not
be valid, Le., the lanes having the highest drug and DNase I concentrations, where significant amounts of short fragments were produced, were
not used in the analysis. Although response of photographic film to
ethidium bromide fluorescence has been reported to be nonlinear,I0 no
correction for this effect was made. Gels containing differing amounts
of stained DNA but photographed so as to minimize the illumination/
optic effects (see above) showed that any nonlinearity was minor over the
density range studied. Because of its superhelical nature, the ability of
form I DNA to stain under saturated ethidium bromide conditions was
less than that of forms I1 and I11 DNA: the earlier determined factor
of 0.8 was used to multiply calculated intensities of form I DNA (see
below)." The experimental band intensities as a function of drug concentration or units (DNase I) can be found in Figures 3-6.
The band intensities are proportional to the amounts of the various
forms of DNA present at the end of the digest period T (10 min). The
kinetic models for the interconversion of the various forms of DNA arc
discussed in the next section. Given such a model, one can calculate the
amount of each DNA form for each concentration of cleavage agent, in
terms of the rate constants and the amounts of the three forms present
before reaction with cleavage agent. The rate constants and initial
amounts are parameters determined by seeking the values that minimize
the deviation between the experimental and calculated band intensities.
Thus, if Il1,is the intensity of form i at t = T when the cleavage agent
is the corresponding value calculated
concentration is cl and if
according to a model, we minimize
D

EE(1,,
- I,jak)2
I f

(IO) Pruncll, A.; Straws, F. and Leblanc, E. Anal. Blochem. 1977, 78,

51-65.

( 1 1) Bauer, W.; Vinograd, J. J . Mol. Blol. 1968, 33, 141-171.
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Figure 5. Intensities for forms I, 11, and I11 DNA resulting from esperamicin C cleavage of PM2 DNA as a function of concentration of
esperamicin C. See caption to Figure 3 for further details.

with respect to these parameters. The nonlinear minimization problem
is solved by the Simplex Search Method.I2 With this iterative method,
values of D arc calculated for several sets of values of the parameters.
The calculated values of D indicate in what way the parameters should
be changed to obtain lower values of D,and the process is repeated.

Results and Discussion
In the cases of esperamicin and calicheamicin, an activation
agent has been postulated to produce a diradical possessing two
DNA-damaging equivalents. If both radicals on the phenylene
moiety reach D N A targets, strand scission will be a two-step
kinetic process with reaction of one radical with a site on DNA,
e.g., removing a hydrogen atom from deoxyribose, followed by
the reaction of the second radical with another D N A site. (The
likelihood of a concerted process, Le., identical reaction rates for
the reaction of the two radicals, seems low since it would require
optimal positioning of both radicals relative to their respective
DNA targets.) If the drug did not move from its original position
in the time required for both radicals of the phenylene moiety to
react with DNA targets on opposing strands, the covalently closed
circular form 1 DNA would be converted directly to form 111 DNA
without passing through the nicked circular form I1 DNA. Although the rate constant of hydrogen atom abstraction of the
phenylene diradical of esperamicin and calicheamicin from a donor
has not been measured, studies on related systems suggest that
this constant is large, ,106 M-'s-*, and thus the drug may not
have time to migrate to a new position on D N A before hydrogen
abstraction from some source occurs.13 If only one of the phe(12) Fletcher, R.Pracrlcal Methods of Oprfmizarion; Wiley: Chichester,
1980.
(13) Lockhart, T.P.: Comita, P. 9.;Bergman, R. G . J . Am. Chem. Soc.
1981, 103,40824090.

\

B

Figure 6. Intensities for forms I, 11, and 111 DNA resulting from Calicheamicin cleavage of PM2 DNA as a function of calichcamicin concentration. See caption to Figure 3 for further details.

nylene diradicals reacts with D N A or both react with the same
strand of the polymer, form I would convert to form I1 DNA.
Extensive random cleavage of the latter form would eventually
produce the linear product, form 111 DNA.
The experimental results of the studies involving P M 2 D N A
are shown in Figures 2-6, solid symbols. In the cases of DNAse
I and esp AI (Figures 3 and 4), cleavage caused closed circular
form I DNA to decrease in amount while at the same time nicked
circular form I1 increased in amount. Higher concentrations of
DNAse I or esp A led to a decrease in the amount of form I1 while
linear form 111 D N A increased in amount. This behavior contrasted with that of esp C and calicheamicin, which showed decreases in the amount of form I with concomitant increases in the
amount of form 111 D N A (Figures 5 and 6). These intensity/
concentration plots (Figures 3-6) were analyzed according to the
single- and double-strand cleavage models given below. The
calculated rate constants can be found in Table I.
To model the interconversion of the three forms of PM2 DNA,
we begin by assuming that the rate of nicking of each form of
DNA is proportional to its concentration and to the concentration
of the cleavage agent (DNAse I or drug). Each interconversion
rate is proportional to the rate of nicking. Then, for example,
the rate of decrease of the concentration of the closed circular
form I D N A is d[I]/dt = -k,'[I][P] where kl' is a second-order
rate constant and [PIis the concentration of cleavage agent. The
experimental data for esperamicin and calicheamicin show that
there is little or no change in the concentrations of the three forms
of PM2 D N A over the digest time unless the drug concentrations
exceed about 0.02 pM. Since the concentration of PM2 D N A
(plasmid per unit volume) is only 0.01 pM, and since we believe
almost all the drug is bound to the DNA, this implies that only
a fraction of the drug is activated, so that the drug concentration
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Table I. Rate Constants for Esperamicin, Calicheamicin, and DNase I Cleavage of P M 2 DNA
cleavage anent
model'
k,'b
k,'
k,'
k.r'
D X IOsc
0.09 f 0.03
0.11 f 0.03
1.4
DNase Id
ss
0.49 f 0.07
-0.05 f 0.03
4.5
0.10f 0.05
DNase Id
ds
0.46 f 0.20
6.9
0.07 f 0.08
1.95 f 0.25
ss
0.50f 0.07
esp AI
20.4
1.31 f 0.21
-0.38 f 0.06
-0.11 f 0.10
ds
esp AI
0.94 f 0.10
0.31 f 0.03
0.09 f 0.007
1.2
esp C
ss
0.12 f 0.04
0.00f 0.01
1.4
0.31 f 0.03
esp C
ds
2.51 f 1.5
0.047
0.038 f 0.004
ss
0.015 f 0.010
calicheamicin
0.039 f 0.004
0.046
0.007 f 0.003
0.019 f 0.009
calicheamicin
ds
a Model ss involves only single-strand cleavage, Le., form I
form I1 form I11 DNA. Model ds is for double-strand cleavage, form I form
Ill and form I1 form 111. bSccond-order rate constants in pM-'mi&. CThequantity D is the sum of the squared deviations between experimental
and calculated data. Stated errors are changes producing 10% increase in D. "For DNAse I, the rate constants are in (units/L)-' min-I.

- -

-

[PI remains essentially constant during the time of the digest.
Therefore, all the rate laws are pseudo-first-order. For instance,
we write d[I]/dr = -k,[I], where the pseudo-first-order rate
constant k, is kl' multiplied by [PI.
Single-Strand Cleavage Model. We first consider that the
nicking process converts closed circular DNA, form I, to nicked
circular DNA, form 11, with a rate constant of kl. Subsequent
nicking converts form I1 to linear D N A (form 111) with a rate
constant of k2. Further cleavage of form 111 converts it to undetected forms of DNA with a rate constant of k3 (including all
processes that destroy form 111 DNA). The rate laws are then

d[III]
dr

-=

k2[II] - k3[III]

Integrating these expressions, we have

Here, Co, No, and l,, are, respectively, the initial values of [I],
[II], and [III]. The DNA used in this investigation included forms
I1 and I11 DNA in addition to form I DNA so No and L,, are not
zero. For t in these expressions we will use the digest time 7 (10
min), and for k,, the true rate constant, k[ multiplied by the
concentration of cleavage agent.
Doubk-Strmd Cleavage Model. Another possibility is that the
cleavage agent, nicking the closed circular DNA, converts it
directly to the linear form, ;.e., form I form 111. This is termed
a double-strand.break. The rate laws are then

-

The linear form can be produced from the nicked form, or directly
from form I. Integrating these equations, we obtain

where Co,No, and
forms and
a

4 are the initial concentrations of the three

k4CO/(k3

- k4)

fi = k2NO/(k3

- k2)

-

There are, as in the previous model, six parameters: three rate
constants and three initial concentrations.
Derivation of Rate Constants. For either of the two models,
the amounts or intensities of all three forms may be calculated
for all drug or DNase I concentrations in terms of six parameters:
three rate constants and three initial concentrations (Co,No, 4).
For any set of values for these parameters, calculated intensities
may be compared with the experimental intensities. The parameters are varied to minimize the sum of the squared deviations:
D = x(Iij- Zua'c)2. Here, Zii is the intensity of form i when the
drug or DNase I concentration is cis The values of the secondorder rate constants found by minimization of D, for each model
and for each cleavage agent, are given in Table I, along with the
minimum values of D. In Figures 3-6, we show the intensities
calculated according to the models, using the best values for the
parameters (open symbols).
Comparison of the values of D for different models shows
whether one model is significantly better than another, or whether
the two fit the experimental data equally well. How well the
experimental data are fit may also be judged from Figures 3-6
themselves. Comparison of rate constants helps in understanding
the physical meaning of the models. Due to the fact that the
DNase I concentration is expressed in units and the drug concentration in moles per liter, the rate constants for the enzyme
and drug are not directly comparable. However, comparing the
ratios of rate constants is valid. It should be noted that the value
of k i , the rate constant for conversion of form 111DNA to shorter
fragments, cannot be determined accurately from the data, because
the data are for low drug concentrations, for which the amount
of short fragments produced is small.
DNA Cleavage Mechanism. DNase I. Prior to analyzing the
cleavage data for esperamicin and calicheamicin using the outlined
coupled kinetic approach, we analyzed cleavage of P M 2 D N A
by the enzyme DNase I. This enzyme binds and cleaves D N A
by a well-known mechanism and, under the conditions used in
the study, should cleave via a single-strand process.*J4 DNase
I is a 30-kDa protein that hydrolyzes the phosphodiester backbone
of DNA. Single-crystal X-ray analysis has shown that, when
DNAse I is bound to DNA, the calcium ion at the catalytic site
of the enzyme is positioned near a phosphate group on one strand
of DNA.I4 The metal ion acts as a Lewis acid and, when bound
to the phosphate group, facilitates the hydrolysis of the diester
linkage of DNA.
Table I shows that the single-strand model fits much better than
the double-strand model. The ratio of kl' to k2' for this model
is -5.4. If the affinities of DNAse I for all three forms of PM2
D N A were the same and cleavages were completely random on
both strands, the ratio k l ' / k i would be expected to be 2 orders
of magnitude greater than that found. This estimate is based on
the length of the PM2 DNA genome, 9300 nucleotides, and the
assumption that the formation of form 111 from form I1 requires
cleavages on opposing strands, which are within 6-10 base pairs
of each other. The lower than expected ratio can be due to an
unusually low value of kl' and/or a large value of k i . In other
studies with radiolabeled restriction fragments in the presence of
(14)Suck D.;Lahm. A.; Oefner, C. Nature (London) 1988,332,464-468.
Suck, D.; Oefner, C. Nature (London) 1986, 321, 620-625.
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a closed circular D N A as a carrier, it is evident that the affinity
of DNAse I for the closed circular D N A is much less than its
affinity for linear DNA, e.g., calf thymus DNA.I5 Since the
enzyme must bind in order to cleave DNA, this suggests that kl’,
for cleavage of the closed circular form, will be lower than expected
(due to lower affinity for closed circular DNA). The enzyme may
also cause some double-strand cleavage of DNA, as has been
shown to occur in the presence of Mn2+and Cd+? In the context
of the single-strand cleavage model this would lead to a higher
value of kl), thus also lowering the ratio k l ’ / k i . Although a model
including both single- and double-strand cleavage could be used,
it is unnecessary since a simple, single-strand cleavage model
already fits the data within experimental error. It may be noted
that k i and k{ are about the same size, suggesting that the process
of conversion of form I1 is similar to the process of destruction
of form 111.
As shown in Table I and Figure 3, analysis of the data according
to the double-strand cleavage model leads to a significantly poorer
fit to the experimental intensities than using the single-strand
model. This implies that the former model is not applicable and
DNase I cleaves D N A primarily via a single-strand cleavage
process. Further evidence for this conclusion is the appreciable
negative (and thus unacceptable) value of k; with the doublestrand cutting model.
Esperamicin AI. The single-strand cleavage model fits the data
for this esperamicin analogue, as shown in Table I and Figure
4. An attempt to fit them with the double-strand model led to
a 3-fold increase in the sum of the squared deviations, D, and to
a substantial negative value of kl), showing that esp A I is mainly
a single-strand cleavage agent. The ratio k l ’ / k i for esp A I for
the single-strand model is strikingly similar to that for DNase I
(Table I). Because of the dramatic differences in structure and
cleavage mechanism between the drug and the enzyme, this result
was not expected. Like the enzyme, the drug may have a significantly reduced affinity for the tense form I D N A relative to
the other two forms, which would lower the value of kl’. Although
the drugI6 and the enzyme“ both cleave D N A from its minor
groove, the drug is not likely to be as sensitive as the enzyme to
the nuances of D N A structure. For example, changes in minor-groove width such as would occur between supercoiled form
I and relaxed forms I1 and 111 DNA would be expected to affect
drug binding to a lesser extent than enzyme binding. The fact
that k,’/k< is lower than expected for random single-strand
cleavage may also reflect a certain number of double-strand
cleavages occumng with esp AI. In the context of the singlestrand
model this would cause a higher value of kl) and lower the ratio
k l ’ / k i . D N A cleavage by the drug, unlike the enzyme, is not
expected to be catalytic. The activation mechanism requires the
formation of a phenylene diradical that reacts with hydrogen atom
donors in an irreoersible manner, ultimately forming the aromatized drug esp Z. Esperamicin Z is not capable of cleaving
DNAm2
The single-strand cleavage behavior of esp AI means that one
of the radicals of the phenylene diradical is unproductive with
regard to a detectable strand break in the assay used. Although
further study is warranted, it may be that the “silent” radical reacts
with solvent, the drug itself, or DNA. If the reaction with D N A
involved the cleaved strand or the opposing strand but the hydrogen
atom abstraction did not lead to a break in the sugar-phosphate
backbone of the strand, form I would not convert directly to form
111 DNA. It may be noted that k i is much bigger than k i for
esp AI. The reason for this is not understood, but our data show
that, even at the highest esperamicin concentration, the concentration of form 111 D N A is still rising, which makes the determination of k i from these data problematic.
bperamicin C and Calicbeamicin. Figures 5 and 6 and Table
I show that the cleavage behavior of esp C and calicheamicin is
significantly different from that of esp AI or DNAse I. The sum
~~

~~

~~~~

(15) Dabrowiak, J. C.; Goinga, H. Unpublished results.
(16) Sugiura, Y.; Uesawa, Y.; Tokahashi, Y.; Kuwahara, J.; Golik, J.;
Doyle, T.W.Proc. Nail. Acad. Sci. U.S.A. 1989, 86, 1612.

of the squared deviations, D, in Table I shows that both models,
single strand and double strand, fit the data for esp C and calicheamicin equally well. The fact that both models fit can be
understood by considering the values of kl’ and kl) for the singlestrand model. With k; > kl’ in this model, almost every initial
break in a form I DNA species, converting it to form 11, is quickly
followed by the conversion of form I1 to form 111. This makes
the overall process effectively a double-strand or “simultaneous”
cleavage event: there is very little net production of form I1
because it is immediately converted to form 111. That this is indeed
what is happening may be seen by comparing the calculated
intensities for the two models (dashed lines and open symbols in
Figures 5 and 6). The curves are practically identical, meaning
that the single-strand model is equivalent to the double-strand
model for this choice of parameters.
Obviously, one cannot conclude that double-strand cleavage
is occurring to the exclusion of single-strand cleavage. Both
probably take place, and one could construct a model including
I1 and I 111. Such a model would have
both processes I
an additional parameter (a rate constant). Since the present
six-parameter models fit the data satisfactorily, fitting to a seven-parameter model does not seem a reasonable procedure. The
value of D would certainly decrease, but the values of the parameters determined would not be very meaningful.
In the double-strand cleavage model, the fact that k i is much
less than kql implies that the formation of form 111 from form
I is faster than its formation from form 11. In the single-strand
cleavage model, the ratio k,’/k,’ reflects the ratio of the rate of
I1 111 to the rate of I 11, large values of this ratio signifying
more effective double-strand cleavage. Since kl)/k,’ = 3 for
esperamicin C and 66 for calicheamicin, we conclude that the latter
is more efficient at causing double-strand breaks. From the values
of kl‘ it is also evident that the rate of cleavage of closed circular
form I D N A by calicheamicin is 1 order of magnitude less than
that of esperamicin C and almost 2 orders less than that of esperamicin AI. Whether this is due to differences in the cleavage
rate constants for the compounds or simply a manifestation of
differing affinities that the agents may have for D N A remains
to be determined. However, from the rate data it is clear that
once calicheamicin cleaves one strand of DNA, cleavage of the
opposing strand is rapid.
Although it is not possible to identify the relative locations of
the two breaks in DNA from the agarose gel studies, earlier work
using sequencing methods showed that calicheamicin-induced
breaks are three nucleotides apart and skewed in the 3’-direction
along the strands4 This indicates that the drug is bound in the
minor groove and, as has been recently shown in modeling studies,I7with the warhead portion straddling two base pairs of DNA.
Recent N M R studies’* have further indicated that the sugars of
calicheamicin are “preorganized” and that they adopt a conformation outside of DNA closely matching that of the minor groove.
Although less is known about the binding of esperamicin to DNA,
the skewing in the drugs’ cleavage patterns2 and the ability of
certain other drugsI6 to influence DNA cleavage by esperamicin
indicate that this compound also binds in the minor groove. The
work presented here clearly shows that for esp C the warhead
portion of the drug is situated such that targets on both strands
are readily accessible and that double-strand cleavage occurs with
high probability when compared to esp AI. It is interesting to
note that double-strand cleavage occurs with the two compounds
having a single point of attachment between the oligosaccharide
and the 1S-diyn-3-ene chromophore, e.g., esperamicin C and
calicheamicin. Models (CPK) show that in the case of esperamicin
A I , which has substituents on two positions of the warhead, the
deoxyfucose and the attached anthranilate residue can be proximal
to one of the radicals of the phenylene diradical. Although additional model building involving energy minization will be nec-
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(17) Hawley, R. C.; Kiessling. L. L.; Schreiber, S. L. Proc. Nut/. Acad.
Sci. U.S.A. 1989. 86, 1105-1109.
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essary, this suggests that ‘self-quenching” by the drug of one of
the radicals may be the reason that esp A I cleaves D N A in a
single-strand manner.
Certain of the steps leading to the activation of the warhead
portion of calicheamicin have recently been investigated by N M R
methods.I9 The first-order rate constant for the formation of
aromatized drug from the Michael addition product outside of
DNA is 5 X lo4 s-l. In addition to being second-order rate
constants, the k,‘ in Table I involve all of the individual steps
including drug activation and the processes on DNA leading to
strand breakage and thus cannot be directly compared with the
rate constants of microsteps measured by N M R .
Esperamicin C and calicheamicin are unique in their D N A
cleavage mechanisms. A single activation event on their chromophores leads to a double-strand break in DNA. This behavior
is different from that of neocarzinostatin, which although it breaks
one strand and modifies the second strand requires posttreatment
of the DNA in order to produce a double-strand breaks5,’ Since
(19) De Voss, J. J.; Hangeland. J. J.; Townsend, C. A.; J . Am. Chem. Soc.
1990, 112,4554-4556.

esp A I is more potent as an antitumor agent than is esp C: singleversus double-strand cleavage is not the only factor influencing
cytotoxicity. Cellular uptake and drug delivery very likely also
play major roles in determining the biological effectiveness of the
agents.

Conclusions
By using a coupled kinetic model, we studied the ability of
esperamicin, calicheamicin, and the enzyme DNase I to cause
single- or double-strand cleavage of DNA. The analysis shows
that DNase I and esperamicin A, cleave D N A mainly via a
single-strand process, whereas esperamicin C and calicheamicin
cleave mainly through a double-strand mechanism. Examination
of the structure of the drugs shows that the location of the sugars
on the warhead portion of the agents is a factor influencing single
versus double-strand cleavage of DNA.
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Abstract: The humiditycontrolled singlecrystal transition of disodium adenosine 5’-triphosphate (Na2ATP) between the dihydrate
(1) and trihydrate (2) forms was investigated over the humidity range 5-50% at 23 OC by X-ray analysis. A crystal of 2 formed
at high humidity changes into 1 at low humidity. The transition is reversible. The crystal structure of 1 was determined to
be orthorhombic space group P212121with the cell parameters a = 27.572 (5), b = 21.066 (3), and c = 7.0854 (9) A. The

structure was solved by direct methods and refined to the final R value of 0.097 for 2450 independent reflections. Two water
molecules, which are hydrogen-bonded to the hydroxyl groups of riboses in 2, are lost in 1. The triphosphate linkages are
in helical arrangement, and the adenine bases are highly stacked along the c axis, as for 2. There are two ATP molecules,
A and B, in an asymmetric unit. The conformation of molecule A in 1 resembles that in 2; the ribose is C3’-endo, and the
exocyclic C4’45’ torsion is gauche+. In molecule B, the ribose is CY-endo, and the C4%5’ torsion is gauche-, in contrast
to C2’-endc-C3’-exo, and gauche+ in 2. The torsional angles around the P-0 ester bonds of the triphosphate chains of both
molecules in 1 differ from those in 2 by 8-47O. Conformational flexibility of ATP makes the single-crystal transition possible.
The conformation of molecule B in 1 relates to the conformation of ATP in its complexes with enzymes. The crystal structure
of 2 (Kennard; et al. Proc. R. SOC.London 1971, A325,401-436) was refined to the final R value of 0.1 17 with the newly
collected data, and the original assignment of Na4 and OW4 was interchanged.

Introduction
Adenosine S’-triphosphate (ATP)-enzyme interactions have
been discussed with regard to the crystal structures of enzymeATP (or ATP analogue) complexes.’” For example, in a series
of site-directed mutagenic studies of tyrosyl-tRNA synthetase
(TyrTS), the crystal structure of the TyrTS-tyrosyl adenylate
complex was referred to in order to analyze the ATP-TyrTS
interactions.5 Although the concept of a ‘rigid” nucleotide was
proposed based on conformational analyses of the crystal structures
‘RIKEN.
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t KEK. Present address: Faculty of Pharmaceutical Sciences, University
of Tokyo, Hongo, Bunkyo, Tokyo 1 1 3, Japan.
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of nucleotides,6 the adenosine moiety of ATP-enzyme complex
is sometimes in an “uncommon” conformation; the ribose of the
(1) (a) Monteilhet, C.; Blow, D. M. J . Mol. Biol. 1978,122,407-417. (b)
Rubin. J.; Blow, D. M. J . Mol. Biol. 1981, 145,489-500. (c) Brick, P.; Blow,
D. M. J . Mol. Bioi. 1987, 194,287-297.
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(b) Watson, H. C.; Walker, N. P. C.; Shaw, P. J.; Bryant, T. N.; Wendell,
P. L.; Fothergill, L. A.; Perkins, R. E.; Conroy, S. C.; Dobson, M. J.; Tuite,
M. F.; Kingsman, A. J.; Kingsman, S. M. E M B O J . 1982, I , 1635-1640.
(3) Shoham, M.; Steitz, T. A. J . Mol. Biol. 1980, 140, 1-14.
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